or Try an Advanced Search...

    Technical Analysis for DNTH - Dianthus Therapeutics, Inc.

    Grade Last Price % Change Price Change
    B 28.87 11.55% 2.99
    DNTH closed up 11.55 percent on Monday, July 1, 2024, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical DNTH trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Overbought Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Pocket Pivot Bullish Swing Setup 11.55%
    Volume Surge Other 11.55%
    Wide Bands Range Expansion 11.55%
    Wide Bands Range Expansion 15.85%
    Older End-of-Day Signals for DNTH ...

       Recent Intraday Alerts

    Alert Time
    Up 10% about 5 hours ago
    Rose Above Upper Bollinger Band about 5 hours ago
    Upper Bollinger Band Resistance about 6 hours ago
    Up 1 ATR about 6 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    DNTH Chart by TradingView
    Basic chart:

    Profile

    Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs and delivers novel monoclonal antibodies. It develops monoclonal antibodies and complement therapeutics to deliver transformative medicines for patients with rare diseases. Dianthus Therapeutics, Inc. was incorporated in 2019 and is based in Waltham, Massachusetts, with an additional office in New York, New York
    Classification
    Keywords: Biotechnology Immunology Immune System Antibodies Monoclonal Antibody Rare Diseases Antibody

    Is DNTH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)
    Jun 21 Dianthus Therapeutics: Complement System Candidate Not Sufficiently Derisked
    Jun 12 Dianthus wins FDA nod to start mid-stage trial for lead asset
    Jun 12 Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)
    May 30 Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
    May 21 Companies Like Dianthus Therapeutics (NASDAQ:DNTH) Are In A Position To Invest In Growth
    May 16 H.C. Wainwright starts Dianthus as buy, cites lead drug candidate
    May 9 Dianthus Therapeutics GAAP EPS of -$0.54 misses by $0.10, revenue of $0.87M beats by $0.5M
    May 9 Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
    May 8 Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference
    See more DNTH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 33.77
    52 Week Low 6.58
    Average Volume 260,968
    200-Day Moving Average 18.62
    50-Day Moving Average 23.86
    20-Day Moving Average 24.27
    10-Day Moving Average 25.47
    Average True Range 2.10
    RSI (14) 65.28
    ADX 18.84
    +DI 30.61
    -DI 17.10
    Chandelier Exit (Long, 3 ATRs) 22.60
    Chandelier Exit (Short, 3 ATRs) 26.14
    Upper Bollinger Bands 28.60
    Lower Bollinger Band 19.94
    Percent B (%b) 1.03
    BandWidth 35.70
    MACD Line 0.75
    MACD Signal Line 0.41
    MACD Histogram 0.3375
    Fundamentals Value
    Market Cap 846.42 Million
    Num Shares 29.3 Million
    EPS -2.91
    Price-to-Earnings (P/E) Ratio -9.92
    Price-to-Sales 147.91
    Price-to-Book 2.94
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 34.30
    Resistance 3 (R3) 33.71 31.30 33.40
    Resistance 2 (R2) 31.30 29.92 31.60 33.09
    Resistance 1 (R1) 30.09 29.07 30.70 30.68 32.79
    Pivot Point 27.68 27.68 27.99 27.98 27.68
    Support 1 (S1) 26.47 26.30 27.08 27.06 24.95
    Support 2 (S2) 24.06 25.45 24.36 24.65
    Support 3 (S3) 22.85 24.06 24.35
    Support 4 (S4) 23.44